Clinical compatibility of bromhexine injectable preparations

doi:10.19803/j.1672-8629.20230305

Abstract

Abstract: Objective To investigate the causes of turbidity that occurs during infusion of bromhexine injectable preparations. Methods Representative clinical compatibility tests for verification were carried out in combination with bromhexine solubility analysis, and the relevant compatibility of non therapeutic drugs was observed. Results The solubility of bromhexine was highly correlated with the pH environment. Combined with confirmatory clinical compatibility tests of compound sodium chloride injection and multiple electrolytes injection, it was confirmed that bromhexine injectable preparations were likely to become turbid when the environmental pH value of the clinical compatibility medication was slightly alkaline. Conclusion The turbidity of bromhexine injectable preparations is chiefly due to pH rather than the infusion solvent, suggesting the need to attach importance to clinical compatibility of non-therapeutic drugs.

Key words: bromhexine, injection, clinical compatibility, solubility, pH, sodium chloride injection, non therapeutic drugs, electrolytes, solvent

CLC Number:

R917

LIU Yi, LIU Xiaoqiang, YAO Xiao, LI Xuantang, GUO Xianhui, GENG Ying, PEI Yusheng. Clinical compatibility of bromhexine injectable preparations[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 884-887.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20230305

https://zgywjj.magtechjournal.com/EN/Y2024/V21/I8/884

References

[1] WU J, FAN JY, YANG XQ.Effect of bromhexine hydrochloride combined with azithromycin in treatment of infant mycoplasmal pneumoniae pneumonia[J]. Chinese Community Doctors(中国社区医师), 2023, 39(6): 46-48.
[2] WEI GH, FENG NN.Clinical study of bromohexoxin hydrochloride combined with phentolamine in the treatment of children with pneumonia[J]. China Journal of Pharmaceutical Economics(中国药物经济学), 2022, 17(3): 80-83, 87.
[3] LIN JH, CHEN XJ, DING YL.Study on the bacterial endotoxin test in the raw material of bromhexine hydrochloride for injection[J]. Shanghai Medical & Pharmaceutical Journal(上海医药), 2020, 41(7): 75-77.
[4] LI XL, XIA YH, CHEN YF, et al.Clinical study on bromhexine combined with tiotropium bromide in treatment of chronic obstructive pulmonary disease in stable stage[J]. Drugs & Clinic(现代药物与临床), 2020, 35(1): 105-108.
[5] SUN J, LI Y, DUAN XX, et al.Bioequivalence evaluation of domestic bromhexine hydrochloride soluble powder in chickens[J]. Journal of Qingdao Agricultural University(Ziran Kexueban)(青岛农业大学学报自然科学版), 2022, 39(4): 252-258.
[6] XIAO GR, MAO YH, FANG SQ, et al.Observation on the efficacy of moxifloxacin combined with bromhexin hydrochloride in patients with MRSA severe ventilator-associated pneumonia[J]. Journal of Qiqihar University of Medicine(齐齐哈尔医学院学报), 2022, 43(17): 1634-1638.
[7] MA LJ, YANG L, GONG PS, et al.Efficacy of ceftazidime combined with bromhexine in the treatment of chronic obstructive pulmonary disease complicated with pulmonary infection and the effects of the combination on pulmonary function and inflammatory factors[J]. China Medicine and Pharmacy(中国医药科学), 2022, 12(2): 66-69.
[8] ZHANG W, ZHANG MX, TAN L, et al.Meta-analysis of adverse reactions of bromhexine[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(3): 171-173, 178.
[9] WANG T, WU GZ, DONG Z.Analysis and consideration on risk of bromhexine hydrochloride injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(1): 49-52.
[10] GUAN SX.Efficacy and adverse reactions of bromhexine hydrochloride combined with azithromycin in the treatment of children with mycoplasmal pneumonia[J]. Women’s Health Research(中外女性健康研究), 2019(24): 2-4.
[11] TENG HP.Efficacy and adverse reactions of bromhexine hydrochloride combined with azithromycin in the treatment of children with mycoplasmal pneumonia[J]. China Foreign Medical Treatment(中外医疗), 2019, 38(27): 124-126.
[12] JIANG Y, QI JJ, LI T, et al.Analysis of 208 cases of adverse drug reactions induced by bromhexine hydrochloride injection[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2020, 29(8): 544-548.
[13] NJARIA PM, ABUGA KO, KAMAU FN, et al.A versatile HPLC method for the simultaneous determination of bromhexin, guaifenesin, ambroxol, salbutamol/terbutaline, pseudoephedrine, triprolidine, and chlorpheniramine maleate in cough-cold syrups[J]. Chromatographia, 2016, 79(21): 1507-1514.
[14] National Medical Products Administration. NMPA Public notice for revising the package insert of bromhexine hydrochloride injections(No.89, 2018)[EB/OL]. (2018-11-12) [2023-02-20]. https://www.nmpa.gov.cn/xxgk/ggtg/ypshmshxdgg/20181120170101624.html.
[15] XU MZ, LIU Y, HE L, et al.Study of key factors influencing the quality of bromhexin hydrochloride injectable preparations in clinical use[J]. Chinese Journal of Pharmaceutical Analysis(药物分析杂志), 2021, 41(2): 359-369.
[16] LIU Y, WU JM, LIU XQ, et al.Study on the quality standards of bromhexin hydrochloride injections[J]. Chinese Journal of Pharmaceutical Analysis(药物分析杂志), 2018, 38(11): 2008-2013.